Marrone Bio Innovations Stock

Marrone Bio Innovations FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Marrone Bio Innovations (MBII) as of Jul 25, 2026 is 66.78 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 31,166.04 % — a change of -99.79% (lower).

FCF Conversion

66.78 %

YoY

-99.79%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Marrone Bio Innovations is 2026 66.78 % . FCF Conversion Rate (FCF/EBITDA) of Marrone Bio Innovations was 2025 31,166.04 % . It decreases by -99.79% lower compared to the previous year.
Access this data via the Eulerpool API

Marrone Bio Innovations Stock analysis

What does Marrone Bio Innovations do? Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility. Marrone Bio Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Marrone Bio Innovations stock

FCF Conversion Rate (FCF/EBITDA) of Marrone Bio Innovations is 66.78 % in 2026.

Access this data via the Eulerpool API

Cash Flow — Marrone Bio Innovations

All Key Metrics — Marrone Bio Innovations